MarkNtel Advisors – Leading Market Research Company found Global Cell & Gene Therapy Drug Delivery Devices Market is expected to reach 14% CAGR Growth By 2028.
This report provides a comprehensive analysis of the Global Cell & Gene Therapy Drug Delivery Devices Market, with a focus on market size, segmentation, key players, geographical analysis, and growth in the coming years. The expert team of analysts invested considerable time and effort in collecting and analyzing the latest market data, producing a comprehensive and current report that provides valuable insights for decision-makers, including business owners and analysts.
Comprehensive Analysis of the Cell & Gene Therapy Drug Delivery Devices Market
Base Year: 2022
Forecast Years: 2023-2028
Historical Years: 2018-2021
✅In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.
If you’re interested in the assumptions considered in this study, you can download the PDF brochure- - https://www.marknteladvisors.com/query/request-sample/cell-gene-therapy-drug-delivery-devices-market.html
Scope of the Cell & Gene Therapy Drug Delivery Devices Market Report:
The Global Cell & Gene Therapy Drug Delivery Devices Market is anticipated to grow at a CAGR of around 14% during the forecast period, i.e., 2023-28, says MarkNtel Advisors. The market is driven primarily by massive funding by numerous leading players in the technological advancements to bring cost-effective therapies & devices, coupled with the increasing number of FDA approvals for cell & gene therapies & clinical trials.
Which prominent factor is expected to drive the Cell & Gene Therapy Drug Delivery Devices Market during 2023-28?
The factors that are projected to drive the market in the coming years include the following:
- Substantial investments in R&D, particularly across the US, for the development of new & improved cell & gene therapies
- Mounting prevalence of genetic disorders & chronic diseases
- An increasing number of FDA approvals for cell & gene therapies & their clinical trials.
What are the different Segment Available in the Cell & Gene Therapy Drug Delivery Devices Market?
By Product Type
- Sub-retinal Injection Cannula
- Extension Tube
- Intravenous Catheter
- Sterile Insulin Syringe
- Size 1.0 ML, 31-Gauge Needle
- Size 0.5 ML, 22-Gauge Needle
- Pre-Filled Syringe
- Size 1.0 ML, 22-26 Gauge Needle
- Size 4.0 ML, 22-26 Gauge Needle
- Infusion Bags
- Infusion Bags (Size 10 ML to 50 ML)
- Infusion Bags (Size 68 ML)
- Infusion Bags (Size 60 ML)
- Infusion Bags (Size Up to 65 ML)
By Technology
- Microchip Technology
- Nano-Technology
- Lipid Nanoparticles
By Commercialized Drugs
- Luxturna
- Kymriah
- Yescarta
- Zolgensma
- Provenge
- Strimvelis
By End-User
- Pharmaceuticals & Biotechnology Company
- Academic & Research Institute
- Hospitals & Clinics
By Region
- North America
- South America
- Europe
- Middle East & Africa
- Asia-Pacific.
Browse Full Report Along with TOC and Figures - https://www.marknteladvisors.com/research-library/cell-gene-therapy-drug-delivery-devices-market.html
Leading Cell & Gene Therapy Drug Delivery Devices companies operating in the Market
- Amgen Inc.
- Bausch & Lomb Incorporated
- Becton, Dickinson and Company
- Bluebird bio Inc.
- Castle Creek Biosciences, Inc. (Fibrocell Science, Inc.)
- Dendreon Pharmaceuticals LLC
- Helixmith Co. Ltd (ViroMed Co., Ltd)
- Human Stem Cells Institute
- Kite Pharma Inc.
- Kolon TissueGene, Inc.
- Novartis AG
- Orchard Therapeutics plc.
- Pfizer Inc.
- Renova Therapeutics
- Spark Therapeutics Inc.
- uniQure N.V.
- Vericel Corporation.
*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address
About Us –
We are a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.
Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.
Contact Us –
Call +1 628 895 8081 +91 120 4278433
Email: [email protected]
